[go: up one dir, main page]

WO2003015710A3 - Therapies et systemes combinant l'administration de medicament et l'extraction de liquide cephalorachidien - Google Patents

Therapies et systemes combinant l'administration de medicament et l'extraction de liquide cephalorachidien Download PDF

Info

Publication number
WO2003015710A3
WO2003015710A3 PCT/US2002/026435 US0226435W WO03015710A3 WO 2003015710 A3 WO2003015710 A3 WO 2003015710A3 US 0226435 W US0226435 W US 0226435W WO 03015710 A3 WO03015710 A3 WO 03015710A3
Authority
WO
WIPO (PCT)
Prior art keywords
csf
space
systems
implantable
combined drug
Prior art date
Application number
PCT/US2002/026435
Other languages
English (en)
Other versions
WO2003015710A2 (fr
Inventor
Dawn Mcguire
Tom Saul
Denise F Gottfried
Original Assignee
Eunoe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eunoe Inc filed Critical Eunoe Inc
Priority to AU2002313778A priority Critical patent/AU2002313778A1/en
Publication of WO2003015710A2 publication Critical patent/WO2003015710A2/fr
Publication of WO2003015710A3 publication Critical patent/WO2003015710A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0258—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped by means of electric pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M27/00—Drainage appliance for wounds or the like, i.e. wound drains, implanted drains
    • A61M27/002—Implant devices for drainage of body fluids from one part of the body to another
    • A61M27/006—Cerebrospinal drainage; Accessories therefor, e.g. valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0464—Cerebrospinal fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Selon l'invention, des maladies et d'autres états pathologiques du système nerveux central sont traités par administration d'un agent thérapeutique dans un espace occupé par le fluide céphalorachidien et, de manière simultanée ou séquentielle, évacuation du fluide céphalorachidien de l'espace qu'il occupe. Des systèmes prévus à cet effet comprennent au moins un cathéter implantable servant à accéder à l'espace occupé par le fluide céphalorachidien, en général un espace ventriculaire ou lombaire, ainsi qu'au moins un cathéter servant à évacuer le fluide céphalorachidien vers un autre emplacement, par exemple vers la cavité péritonéale. Des pompes implantables servent à administrer l'agent thérapeutique par l'intermédiaire du cathéter donnant accès à l'espace occupé par le fluide céphalorachidien et des mécanismes de régulation de débit implantables sont utilisés pour réguler le débit et le volume du fluide céphalorachidien évacué dudit espace.
PCT/US2002/026435 2001-08-21 2002-08-19 Therapies et systemes combinant l'administration de medicament et l'extraction de liquide cephalorachidien WO2003015710A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002313778A AU2002313778A1 (en) 2001-08-21 2002-08-19 Combined drug and csf removal therapies and systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31393801P 2001-08-21 2001-08-21
US60/313,938 2001-08-21

Publications (2)

Publication Number Publication Date
WO2003015710A2 WO2003015710A2 (fr) 2003-02-27
WO2003015710A3 true WO2003015710A3 (fr) 2004-02-12

Family

ID=23217836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/026435 WO2003015710A2 (fr) 2001-08-21 2002-08-19 Therapies et systemes combinant l'administration de medicament et l'extraction de liquide cephalorachidien

Country Status (2)

Country Link
AU (1) AU2002313778A1 (fr)
WO (1) WO2003015710A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11278657B2 (en) 2019-04-11 2022-03-22 Enclear Therapies, Inc. Methods of amelioration of cerebrospinal fluid and devices and systems therefor
US11419921B2 (en) 2018-07-23 2022-08-23 Enclear Therapies, Inc. Methods of treating neurological disorders
US11752200B2 (en) 2018-07-23 2023-09-12 Enclear Therapies Inc. Methods of treating neurological disorders
US12329930B2 (en) 2020-09-29 2025-06-17 Enclear Therapies, Inc. Subarachnoid fluid management method and system

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1324800T3 (da) 2000-09-11 2008-11-10 Csf Dynamics As Væskeshuntsystem til behandling af hydrocephalus
ES2307396B1 (es) * 2006-09-14 2009-09-30 Fundacion Para Investigaciones Neurologicas (Fin) Sistemas de eliminacion de sustancias neurotoxicas causantes de enfermedades neurodegenerativas mediante su atrapamiento selectivo por inmunoafinidad en el liquido cefalo-raquideo circulante.
US10632237B2 (en) 2006-10-09 2020-04-28 Minnetronix, Inc. Tangential flow filter system for the filtration of materials from biologic fluids
US10850235B2 (en) 2006-10-09 2020-12-01 Minnetronix, Inc. Method for filtering cerebrospinal fluid (CSF) including monitoring CSF flow
ES2845146T3 (es) 2006-10-09 2021-07-26 Neurofluidics Inc Sistema de purificación de líquido cefalorraquídeo
WO2011114260A1 (fr) 2010-03-19 2011-09-22 Pfizer Inc. Système de purification de liquide céphalorachidien
US20150038948A1 (en) * 2013-07-31 2015-02-05 G-Tech Electronic Research & Development, LLC Apparatus and use of a neurochemisrty regulator device insertable in the cranium for the treatment of cerebral cortical disorders
WO2015049588A2 (fr) * 2013-10-01 2015-04-09 Md Start Sa Systèmes et procédés de déplacement et de circulation de fluide pour traiter la maladie d'alzheimer
US11147540B2 (en) 2015-07-01 2021-10-19 Minnetronix, Inc. Introducer sheath and puncture tool for the introduction and placement of a catheter in tissue
EP3714915B1 (fr) 2015-08-05 2021-11-03 Minnetronix Inc. Système de filtration à flux tangentiel pour la filtration de matériaux provenant de fluides biologiques
CN108778355B (zh) 2015-12-04 2021-04-30 米奈特朗尼克斯有限公司 用于对脑脊液进行调节的系统及方法
CN107088257B (zh) * 2017-04-27 2023-06-09 哈尔滨医科大学 一种y型两用双腔两囊引流器
US11559626B2 (en) 2020-04-08 2023-01-24 Medtronic, Inc. Means to treat Alzheimer's disease via flushing of brain parenchyma

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5957912A (en) * 1998-04-16 1999-09-28 Camino Neurocare, Inc. Catheter having distal stylet opening and connector
US6193691B1 (en) * 1999-03-30 2001-02-27 Depuy Orthopaedics, Inc. Catheter system
US6210346B1 (en) * 1989-10-11 2001-04-03 Edwards Lifesciences Corp. Method for inserting an intracranial catheter and for monitoring intracranial pressure in a mammal
US20030135148A1 (en) * 2002-01-14 2003-07-17 Dextradeur Alan J. Multi-catheter insertion device and method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210346B1 (en) * 1989-10-11 2001-04-03 Edwards Lifesciences Corp. Method for inserting an intracranial catheter and for monitoring intracranial pressure in a mammal
US5957912A (en) * 1998-04-16 1999-09-28 Camino Neurocare, Inc. Catheter having distal stylet opening and connector
US6193691B1 (en) * 1999-03-30 2001-02-27 Depuy Orthopaedics, Inc. Catheter system
US20030135148A1 (en) * 2002-01-14 2003-07-17 Dextradeur Alan J. Multi-catheter insertion device and method

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11419921B2 (en) 2018-07-23 2022-08-23 Enclear Therapies, Inc. Methods of treating neurological disorders
US11752200B2 (en) 2018-07-23 2023-09-12 Enclear Therapies Inc. Methods of treating neurological disorders
US11278657B2 (en) 2019-04-11 2022-03-22 Enclear Therapies, Inc. Methods of amelioration of cerebrospinal fluid and devices and systems therefor
US12350416B2 (en) 2019-04-11 2025-07-08 Enclear Therapies, Inc. Methods of amelioration of cerebrospinal fluid and devices and systems therefor
US12329930B2 (en) 2020-09-29 2025-06-17 Enclear Therapies, Inc. Subarachnoid fluid management method and system
US12337140B2 (en) 2020-09-29 2025-06-24 Enclear Therapies, Inc. Subarachnoid fluid management method and system with varying rates

Also Published As

Publication number Publication date
AU2002313778A1 (en) 2003-03-03
WO2003015710A2 (fr) 2003-02-27

Similar Documents

Publication Publication Date Title
WO2003015710A3 (fr) Therapies et systemes combinant l'administration de medicament et l'extraction de liquide cephalorachidien
US7887503B2 (en) Method and apparatus for removing harmful proteins from a mammalian's ventricular cerebrospinal fluid
EP1342481B1 (fr) Dispositif implantable pour l'administration de médicaments
US20230058368A1 (en) Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor
EP3052179B1 (fr) Systèmes de déplacement et de circulation de fluide pour traiter la maladie d'alzheimer
US11541175B2 (en) Therapeutic applications of artificial cerebrospinal fluid and tools provided therefor
WO2006044115A3 (fr) Procede de traitement de la maladie de parkinson chez des humains par la perfusion activee par convection du facteur neurotrophique derive de lignee de cellules gliales au putamen
WO2006014764A3 (fr) Dispositif de drainage de fluide spinal cerebral implantable et procede de drainage de fluide spinal cerebral
WO2004008826A3 (fr) Systemes et procedes de dialyse peritoneale
CA2356032A1 (fr) Valve
WO2005061026A3 (fr) Systemes et procedes de controle de flux de therapie fluidique medicale
CA2421727A1 (fr) Systeme de derivation de liquide et methode de traitement de l'hydrocephalie
WO2003066123A3 (fr) Dispositif de micro-perfusion
WO2006135766A3 (fr) Therapies localisees pour traiter la douleur
DE60023668D1 (de) Für das zentrale nervensystem bestimmer katheter mit temperaturkontrollsystem
WO2005028015A3 (fr) Procedes et appareil d'administration localisee et semi-localisee de medicament
WO2003068049A3 (fr) Systeme d'infusion et de derivation cerebro-spinales controlees
WO2007127853A3 (fr) Systeme implantable d'administration de substance therapeutique avec commande d'orifice d'acces de catheter et procede d'utilisation
WO2007130718A3 (fr) Micro-système implantable pour le traitement de l'hydrocéphalie
MXPA04006534A (es) Sistema de infusion.
CA2486934C (fr) Systemes de drainage du lcr
Weiss et al. Influence of nitroprusside on cerebral pressure autoregulation
Turner The treatment of hydrocephalus: A brief guide to shunt selection
WO2006087420A3 (fr) Technique de traitement d'insuffisance cardiaque
US20070055196A1 (en) Implantable shunt system and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP